- Published on
Ophthalmology – Anophthalmia
Anophthalmia is a rare congenital condition characterized by the complete absence of the globe. It must be carefully distinguished from severe microphthalmia, in which small remnants of ocular tissue may still be present but are only detectable with imaging or histologic evaluation. The condition may occur in isolation or as part of a broader systemic or syndromic disorder. It can affect one eye (unilateral) or both eyes (bilateral), with significant implications for visual development and overall prognosis.
The condition has an estimated incidence of approximately 10–19 per 100,000 newborns. Risk factors include chromosomal abnormalities, congenital syndromes, and intrauterine exposures to teratogenic agents such as radiation, alcohol, thalidomide, retinoic acid, hydantoin, and certain drugs like lysergic acid diethylamide. Although genetic factors are implicated, no single gene defect has been identified as specifically responsible for true anophthalmia. Preventive strategies include prenatal ultrasound screening and avoidance of teratogenic exposures during pregnancy.
Pathophysiologically, anophthalmia results from complete failure of development of the primary optic vesicle during embryogenesis. The etiology may be genetic, environmental, or idiopathic. The condition is often associated with other abnormalities, including midline craniofacial defects and, in some cases, significant developmental delay, particularly when part of a chromosomal or syndromic disorder.
Clinically, patients present with absence of the globe and reduced orbital volume, often resulting in an enophthalmic appearance and small palpebral fissures. Eyelids may appear normal, small, or partially fused, while adnexal structures such as eyelashes, tarsal glands, and the lacrimal system are usually present. A thorough systemic examination is essential to identify associated anomalies, particularly involving the brain and craniofacial structures. Examination of the parents may help differentiate true anophthalmia from severe microphthalmia, especially if features such as coloboma are identified in family members.
Diagnosis is supported by imaging studies such as MRI or CT scans, which confirm the absence of ocular tissue, optic nerve, and extraocular muscles. In cases with associated anomalies, genetic testing including karyotyping or microarray analysis may be indicated. Serial imaging may also be useful in monitoring orbital bone development over time.
The differential diagnosis includes severe microphthalmia, cystic eye, acquired anophthalmia due to trauma or surgery, phthisis bulbi following severe ocular disease, and rare conditions such as cyclopia or synophthalmia. Distinguishing between these entities is important for prognosis and management.
Management is primarily supportive and focuses on promoting normal orbital and facial development, as well as optimizing cosmetic outcomes. In unilateral cases, protection of the remaining functional eye with safety glasses is essential. The use of a scleral shell or conformer helps stimulate growth of the orbit and surrounding tissues. In more severe cases, surgical interventions such as placement of progressively enlarging orbital expanders, dermal fat grafts, or intraorbital balloons may be required to support orbital development.
Long-term care involves regular follow-up with an ocularist to adjust prostheses and monitor orbital growth, especially during the first five years of life when development is most rapid. Monitoring of developmental milestones and school performance is also important, particularly in children with associated systemic abnormalities. Referral to genetic counseling and support services for visual impairment is recommended.
The prognosis varies widely and depends largely on the presence and severity of associated systemic anomalies. Isolated unilateral anophthalmia may have a relatively good functional outcome with appropriate management, whereas bilateral cases or those associated with significant neurologic or systemic abnormalities often carry a more guarded prognosis.
Anophthalmia is a rare congenital condition characterized by the complete absence of the globe. It must be carefully distinguished from severe microphthalmia, in which small remnants of ocular tissue may still be present but are only detectable with imaging or histologic evaluation. The condition may occur in isolation or as part of a broader systemic or syndromic disorder. It can affect one eye (unilateral) or both eyes (bilateral), with significant implications for visual development and overall prognosis.
The condition has an estimated incidence of approximately 10–19 per 100,000 newborns. Risk factors include chromosomal abnormalities, congenital syndromes, and intrauterine exposures to teratogenic agents such as radiation, alcohol, thalidomide, retinoic acid, hydantoin, and certain drugs like lysergic acid diethylamide. Although genetic factors are implicated, no single gene defect has been identified as specifically responsible for true anophthalmia. Preventive strategies include prenatal ultrasound screening and avoidance of teratogenic exposures during pregnancy.
Pathophysiologically, anophthalmia results from complete failure of development of the primary optic vesicle during embryogenesis. The etiology may be genetic, environmental, or idiopathic. The condition is often associated with other abnormalities, including midline craniofacial defects and, in some cases, significant developmental delay, particularly when part of a chromosomal or syndromic disorder.
Clinically, patients present with absence of the globe and reduced orbital volume, often resulting in an enophthalmic appearance and small palpebral fissures. Eyelids may appear normal, small, or partially fused, while adnexal structures such as eyelashes, tarsal glands, and the lacrimal system are usually present. A thorough systemic examination is essential to identify associated anomalies, particularly involving the brain and craniofacial structures. Examination of the parents may help differentiate true anophthalmia from severe microphthalmia, especially if features such as coloboma are identified in family members.
Diagnosis is supported by imaging studies such as MRI or CT scans, which confirm the absence of ocular tissue, optic nerve, and extraocular muscles. In cases with associated anomalies, genetic testing including karyotyping or microarray analysis may be indicated. Serial imaging may also be useful in monitoring orbital bone development over time.
The differential diagnosis includes severe microphthalmia, cystic eye, acquired anophthalmia due to trauma or surgery, phthisis bulbi following severe ocular disease, and rare conditions such as cyclopia or synophthalmia. Distinguishing between these entities is important for prognosis and management.
Management is primarily supportive and focuses on promoting normal orbital and facial development, as well as optimizing cosmetic outcomes. In unilateral cases, protection of the remaining functional eye with safety glasses is essential. The use of a scleral shell or conformer helps stimulate growth of the orbit and surrounding tissues. In more severe cases, surgical interventions such as placement of progressively enlarging orbital expanders, dermal fat grafts, or intraorbital balloons may be required to support orbital development.
Long-term care involves regular follow-up with an ocularist to adjust prostheses and monitor orbital growth, especially during the first five years of life when development is most rapid. Monitoring of developmental milestones and school performance is also important, particularly in children with associated systemic abnormalities. Referral to genetic counseling and support services for visual impairment is recommended.
The prognosis varies widely and depends largely on the presence and severity of associated systemic anomalies. Isolated unilateral anophthalmia may have a relatively good functional outcome with appropriate management, whereas bilateral cases or those associated with significant neurologic or systemic abnormalities often carry a more guarded prognosis.
0 Comments
